Related Experiment Video
Updated: Jun 22, 2026
08:36
The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Minocycline may attenuate postherpetic neuralgia
Qiang Zhang1, Liping Peng, Deren Zhang
1Department of Pain Management, Shenzhen Nanshan Hospital, Shenzhen 518052, Guangdong Province, China. zhsz2003@yahoo.com.cn
Medical Hypotheses
|May 27, 2009
Summary
Minocycline may treat postherpetic neuralgia (PHN) by targeting glial cell activation. This research explores minocycline
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Postherpetic neuralgia (PHN) is a chronic pain complication of herpes zoster.
- PHN pathogenesis involves peripheral nerve damage and central sensitization via glial cell activation.
- Glial cells, including microglia and astrocytes, play a key role in pain signaling.
Purpose of the Study:
- To investigate the potential of minocycline in attenuating PHN.
- To explore the hypothesis that minocycline inhibits glial cell activation and metabolism in PHN.
- To assess minocycline's neuroprotective and anti-inflammatory effects in the context of neuropathic pain.
Main Methods:
- Review of existing literature on PHN pathophysiology and glial cell involvement.
- Examination of minocycline's known neuroprotective and microglial inhibitory properties.
- Hypothetical modeling of minocycline's mechanism of action in PHN.
Main Results:
- Minocycline has demonstrated efficacy in experimental neuropathic pain models.
- Minocycline acts as a selective microglial inhibitor, reducing neuroinflammation.
- Evidence suggests glial modulators possess antiallodynic and antihyperalgesic properties.
Conclusions:
- Minocycline holds promise for treating PHN by modulating glial cell activity.
- Further research is warranted to confirm minocycline's therapeutic potential for PHN.
- Targeting glial cells represents a potential therapeutic strategy for chronic neuropathic pain conditions like PHN.
Related Concept Videos
01:20Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:12Local Anesthetics: Adverse Effects
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...